
A new health care company was quietly incorporated last month, with plans to leverage cutting-edge inhalation technology and oral delivery expertise to treat everything from neurology to cardiovascular emergencies.
The multibillion-dollar company, Vectura Fertin Pharma, stands out not simply for its ambitions, but because of its financial backer: Philip Morris International, the tobacco behemoth whose cigarettes are sold in more than 180 countries.
Create a display name to comment
This name will appear with your comment